The efficacy of Bortezomib-based regimens on survival state in newly diagnosed multiple myeloma patients
KM Hasan - Cellular and Molecular Biology, 2024 - mail.cellmolbiol.org
The prognosis of patients with multiple myeloma (MM) has significantly improved over the
past ten years because of several innovative treatments, including the proteasome inhibitor …
past ten years because of several innovative treatments, including the proteasome inhibitor …